Alector Inc (ALEC)
5.30
-0.02
(-0.38%)
USD |
NASDAQ |
May 07, 16:00
5.285
-0.02
(-0.28%)
Pre-Market: 20:00
Alector Revenue (TTM): 97.06M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 97.06M |
| September 30, 2023 | 96.31M |
| June 30, 2023 | 102.06M |
| March 31, 2023 | 125.69M |
| December 31, 2022 | 133.62M |
| September 30, 2022 | 133.17M |
| June 30, 2022 | 300.73M |
| March 31, 2022 | 227.45M |
| December 31, 2021 | 207.08M |
| September 30, 2021 | 197.94M |
| June 30, 2021 | 21.44M |
| Date | Value |
|---|---|
| March 31, 2021 | 18.04M |
| December 31, 2020 | 21.10M |
| September 30, 2020 | 22.25M |
| June 30, 2020 | 19.04M |
| March 31, 2020 | 22.78M |
| December 31, 2019 | 21.22M |
| September 30, 2019 | 24.36M |
| June 30, 2019 | 28.17M |
| March 31, 2019 | 28.36M |
| December 31, 2018 | 27.68M |
| September 30, 2018 | 21.59M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
18.04M
Minimum
Mar 2021
300.73M
Maximum
Jun 2022
95.76M
Average
96.31M
Median
Sep 2023
Revenue (TTM) Benchmarks
| AbbVie Inc | 54.40B |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |